VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

VolitionRx Receives Notice of Non-Compliance with NYSE American Continued Listing Standards [Accessibility Statement] Skip NavigationHENDERSON, Nev., Feb. 9, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition" or the "Company"), a multi-national epigenetics company, announced today that on February 6, 2026, it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") stating that the Company is not in compliance with the NYSE American continued listing standards ...